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Abstract
Ulcerative colitis is a chronic inflammatory disease of the colon that presents as diarrhea and 
gastrointestinal bleeding. We performed a genome-wide association study using DNA samples 
from 1,052 individuals with ulcerative colitis and pre-existing data from 2,571 controls, all of 
European ancestry. In an analysis that controlled for gender and population structure, ulcerative 
colitis loci attaining genome-wide significance and subsequent replication in two independent 
populations were identified on chromosomes 1p36 (rs6426833, combined P = 5.1×10−13, 
combined OR = 0.73) and 12q15 (rs1558744, combined P = 2.5×10−12, combined OR = 1.35). In 
addition, combined genome-wide significant evidence for association was found in a region 
spanning BTNL2 to HLA-DQB1 on chromosome 6p21 (rs2395185, combined P = 1.0×10−16, 
combined OR = 0.66) and at the IL23R locus on chromosome 1p31 (rs11209026, combined P = 
1.3×10−8, combined OR = 0.56; rs10889677, combined P = 1.3×10−8, combined OR = 1.29).
Ulcerative colitis (UC) and Crohn’s disease (CD) are the two major forms of inflammatory 
bowel disease (IBD). Extensive evidence suggests that IBD occurs when ubiquitous 
commensal enteric bacteria initiate and perpetuate a dysregulated mucosal immune response 
in genetically susceptible individuals1. CD and UC share many characteristics but unique 
clinical features also distinguish them, suggesting that they share some genetic susceptibility 
loci but differ at others.
Genome-wide association studies (GWAS) in CD and a CD GWAS meta-analysis provide 
genome-wide significant evidence for 32 CD loci2–7. The most significant CD-associated 
loci include IL23R, NOD2, ATG16L1 and a gene desert on chromosome 5p13, implicating 
both the innate and acquired immune responses. A non-synonymous SNP scan found 
association between UC and ECM1 on chromosome 1q218. The same study and another 
also reported association between UC and some CD loci8,9. A GWAS in a pediatric-onset 
IBD sample identified general IBD loci on chromosomes 20q13 and 21q2210. A UC GWAS 
in European samples found combined, genome-wide significant evidence for association 
with IL10 and other suggestive associations11. There are many reports of UC association 
with HLA Class II alleles12 and major histocompatibility complex (MHC) SNPs8,10,11.
We conducted a GWAS that included 1,052 individuals with UC extending beyond the 
rectum and 2,571 controls, all of white, non-Hispanic, European ancestry. Principal 
components of ancestry analysis demonstrated population structure (see Supplementary Fig. 
1 online). We used genetic matching (GEM) within gender to control for structure and 
potential effects of gender, followed by allelic association tests by conditional logistic 
regression on gender-ancestry strata13 (see Supplementary Table 1 online). GEM reduces 
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the false positive rate attributable to ancestry mismatches between cases and controls13. The 
genomic control inflation factor14 in the combined GEM results was 1.04 compared to 1.17 
for pre-GEM traditional chi square tests for allelic association. Quantile-quantile plots 
showed deviation from expectation at a substantially higher chi-square value in the GEM 
dataset (see Supplementary Fig. 2b online) compared to the pre-GEM dataset (see 
Supplementary Fig. 2a online). A second stage of our study aimed to replicate association in 
two regions that showed genome-wide significance and to extend the association evidence at 
other independent loci with GWAS P values less than 1×10−4 (see Supplementary Table 2 
online). P less than 1×10−4 was the chosen threshold for our follow-up studies because the 
corresponding chi-square value (15.136) is just above the point where the quantile-quantile 
plot of GEM results began to deviate from expectation (see Fig. 2b online). Two 
independent replication samples included 768 UC cases and 721 controls from North 
America, all of white, non-Jewish, non-Hispanic, European ancestry, and 619 UC cases and 
394 controls from southern Italy after quality control (see Supplementary Table 1 online).
Genome-wide significant association in the GWAS with subsequent replication was 
observed on chromosome 1p36 (see Table 1 and Figure 1a) at the correlated (r2 = 0.76) 
markers rs6426833 (GWAS P = 6.8×10−10, GWAS and replication combined P = 
5.1×10−13) and rs10753575 (GWAS P = 2.0×10−9, GWAS and replication combined P = 
9.4×10−11). A residual association signal was observed for rs6426833 but not rs10753575 
when these SNPs were paired in a conditional analysis of their GWAS data (see 
Supplementary Table 3 online). A third SNP in this region, rs3806308, also showed 
genome-wide significant association in the GWAS with subsequent replication (GWAS P = 
4.7×10−8, GWAS and replication combined P = 6.7×10−9); rs3806308 was not correlated 
with either rs6426833 or rs10753575 (r2 < 0.01) and residual association signals were 
observed when rs3806308 and each of the other two SNPs were paired in conditional 
analyses of their GWAS data (see Supplementary Table 3 online). Therefore, the 
chromosome 1p36 locus has at least two independent association signals (rs6426833 and 
rs3806308) separated by recombination hotspots (see Figure 1a). There was also significant 
transmission/disequilibrium test (TDT)15 evidence for under-transmission of the rs6426833 
G allele (transmitted:untransmitted = 197:239, P = 4.4×10−2) in 436 trios of UC GWAS or 
replication cases and their parents.
On chromosome 12q15 (see Table 1 and Figure 1d), genome-wide significant evidence for 
association and subsequent replication was observed at rs1558744 (GWAS P = 5.5×10−10, 
GWAS and replication combined P = 2.5×10−12). rs7134599, which was correlated with 
rs1558744 (r2 = 0.92), showed association evidence equivalent to the evidence for 
rs1558744 in a conditional analysis of the GWAS data (see Supplementary Table 3 online) 
and genome-wide significant combined evidence for association in the GWAS and 
replication samples (GWAS P = 5.4×10−7, GWAS and replication combined P = 6.0×10−9). 
rs2870946, which was only weakly correlated with rs1558744 and rs7134599 (r2 = 0.031 
and 0.029, respectively), showed suggestive combined evidence for association in the 
GWAS and replication samples that was close to the threshold for genome-wide significance 
(GWAS P = 1.0×10−5, GWAS and replication combined P = 4.8×10−7), and residual 
association signals were observed when rs2870946 and each of the other two SNPs were 
paired in conditional analyses of the GWAS data (see Supplementary Table 3 online). 
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Therefore, the chromosome 12q15 locus appears to have two independent association 
signals (rs1558744 and rs2870946) separated by recombination hotspots (see Figure 1d). 
The rs1558744 A allele also showed TDT15 evidence for association with UC 
(transmitted:untransmitted = 238:180, P = 4.6×10−3).
The GWAS and replication samples showed combined genome-wide significant evidence 
for association at two additional loci which have been implicated in UC previously, namely 
IL23R (interleukin 23 receptor) on chromosome 1p312 (see Table 1 and Figure 1b) and the 
MHC on chromosome 6p218,10–12 (see Supplementary Table 2 online, Table 1, and Figure 
1c). Conditional analyses of the UC GWAS data suggest that there are at least two 
independent association signals in the IL23R region, consistent with our earlier study which 
identified the CD- and UC-associated IL23R locus2, and multiple independent association 
signals in the MHC (see Supplementary Table 3). The most significantly associated SNPs at 
the IL23R and MHC loci also showed TDT15 evidence for association with UC 
(rs111209026 A allele, transmitted:untransmitted = 25:63, P = 5.1×10−5; rs10889677 A 
allele, transmitted:untransmitted = 223:150, P = 1.6×10−4; rs2395185 A allele, 
transmitted:untransmitted = 121:224, P = 2.9×10−8). See Supplementary Note online for 
further discussion about the association evidence at rs2395185.
OTUD3 (OTU domain containing 3) and part of PLA2G2E (phospholipase A2, group IIE) 
are located within an approximately 100 kb region containing the most significant 
chromosome 1p36 association signal (rs6426833, see Figure 1a). OTUD3 is expressed 
broadly and has homology to an OTU-like cysteine protease16. PLA2G2E is a compelling 
candidate, as the sPLA2 family of proteins releases arachidonic acid from membrane 
phospholipids which leads to the production of proinflammatory lipid mediators, such as 
prostaglandins and leukotrienes17. Furthermore, PLA2G2E expression in the lung and small 
intestine is induced with lipopolysaccharide stimulation, suggesting a role in bacterial-
associated inflammation17,18. The second independent association signal on chromosome 
1p36 (rs3806308, see Figure 1a) is located within 1.1 kb of RNF186 (ring finger protein 
186). Ring finger proteins are involved in ubiquitination of proteins and diverse cellular 
processes19.
The most significant chromosome 12q15 association signal (rs1558744, see Figure 1d) is 
located in a region that is devoid of established coding genes, but the IFNG (interferon, 
gamma; IFNγ), IL26 (interleukin 26), and IL22 (interleukin 22) genes are located 44 kb, 91 
kb, and 137 kb, respectively, telomeric to rs1558744. A second, highly suggestive 
association signal at rs2870946 is independent of rs1558744 and located in IL26 (see Figure 
1d). IFNγ is critical in the immune response to pathogens, in part through regulation of 
macrophage function; it regulates numerous levels of immune homeostasis including T cell 
subsets, NK cells and NK T cells20. IL22 and IL26 are secreted by Th17 cells, which 
mediate host defense to infections as well as tissue inflammation in many chronic, immune-
mediated diseases, including IBD21. In addition to a role in mediating host defense to 
bacterial pathogens21, IL-22 can mediate protection during acute inflammation, including 
intestinal inflammation22.
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The chromosome 6p21 association signal maps to a broad region (see Supplementary Table 
2 online) that spans many genes in the MHC and demonstrates extensive linkage 
disequilibrium. However, the maximal association signal at rs2395185 is located in an 
approximately 300 kb interval spanning the BTNL2 (butyrophilin-like 2), HLA-DRA, HLA-
DRB5, HLA-DRB1, HLA-DQA1 and HLA-DQB1 genes (see Figure 1c). This region was also 
implicated in other studies8,10–12. rs9268877 showed the most significant evidence for 
association with UC in a study by Franke et al.11 and is correlated (r2 = 0.61) in HapMap 
CEU data23 with rs6903608, which was the second most significantly associated MHC SNP 
in our UC GWAS (see Supplementary Table 2 online). rs2516049, which was correlated 
with rs2395185 (r2 = 0.80) and showed association evidence equivalent to that for 
rs2395185 in our UC GWAS data (see Supplementary Table 3 online), demonstrated 
association that was nearly as significant as the evidence for the maximally associated MHC 
SNP in a study by Kugathasan et al10. The rs2395185 risk allele was associated with 
increased average expression of HLA-DRB1 and HLA-DQA1 in a lymphoblastoid cell line 
eQTL analysis24.
Of the remaining loci tested in our replication samples (see Supplementary Table 2 online), 
a cluster of SNPs on chromosome 7q31 flanked on one side by SLC26A3 (solute carrier 
family 26, member 3) or located within DLD (dihydrolipoamide dehydrogenase) or LAMB1 
(laminin, beta 1) on the other side showed promising extension of the evidence for 
association (rs4730276, combined P = 9.0×10−6; rs4598195, combined P = 9.6×10−7; 
rs2158836, combined P = 6.7×10−6). LAMB1 is a plausible functional candidate since 
laminins play a role in intestinal health and disease25.
Finally, we determined whether CD loci implicated in a recent meta-analysis and CD or UC 
loci reported in other studies showed evidence for association in our UC GWAS (see 
Supplementary Table 4 online). When we assessed the best UC GWAS proxy for each 
previously implicated SNP, we observed only nominally (P < 0.05) significant (see 
Supplementary Table 4a online) or no significant (see Supplementary Table 4b online) 
evidence for association with these loci in our UC GWAS and no significant evidence for 
association for some of these loci that we tested in the replication samples (see 
Supplementary Tables 4a and 4b online).
In this study, we identified UC loci on chromosomes 1p36 and 12q15 where compelling 
candidate genes include PLA2G2E, IFNG, IL26 and IL22. We also confirmed association 
between UC and the MHC region, where associated SNPs are correlated with altered HLA 
Class II expression, and between UC and IL23R. This report extends the model suggesting 
that there exist both unique as well as shared genetic factors for UC and CD. It is highly 
likely that additional UC loci remain to be found since our study had limited power to detect 
small effect sizes, especially for lower risk allele frequencies (see Supplementary Table 5 
online)26. The experience in CD and other complex traits is that individual studies with 
sample sizes similar to the present study sample are sufficiently powered to detect risk loci 
with larger effects but find only a fraction of loci with smaller effects; loci with smaller 
effects can be detected via meta-analysis of the individual studies7. The loci identified 
through GWAS may eventually establish important new therapeutic targets for the treatment 
of IBD.
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METHODS
UC GWAS study subjects, genotyping and analysis
1,052 white, non-Hispanic, European ancestry patients with UC extending beyond the 
rectum and 2,571 white, European ancestry controls were genotyped using Illumina 
HumanHap300v1, HumanHap300v2, HumanHap550v1 or HumanHap550v3 Genotyping 
BeadChips (Illumina, Inc., San Diego, CA,) at the Feinstein Institute for Medical Research. 
Control data were obtained from our CD GWAS2,4 or from studies 64 and 65 deposited in 
the Illumina iControlDB (http://www.illumina.com/pages.ilmn?ID=231). Informed consent 
was obtained using protocols approved by each local institutional review board. More details 
about study subjects and the Illumina Genotyping BeadChips used to genotype groups of 
study subjects are available in the Supplementary Methods and Supplementary Table 1 
online.
Data management and quality control filtering are described in the Supplementary Methods 
online. Case-control matching, by gender and ancestry, followed by association analyses by 
conditional logistic regression on gender-ancestry strata in the matched datasets (see 
Supplementary Table 1 online) were performed using GEM13. The GEM analysis is 
described in more detail in the Supplementary Methods online. The genomic control 
inflation factor was computed14. SNPs with nominal P values < 5×10−8 were considered to 
have genome-wide significant evidence for association27.
Replication study subjects, genotyping and analysis
Two independent replication samples were included in the second stage of our study (see 
Supplementary Table 1 online). A North American replication sample consisted of 769 
patients with UC and 727 controls, all of white, non-Jewish, non-Hispanic, European 
ancestry. The second replication sample consisted of 633 patients with UC and 415 controls 
from southern Italy.
SNPs with UC GWAS P values < 1×10−4 were included on a list of replication genotyping 
candidates with priority scores for inclusion in the replication genotyping assigned 
according to significance of the association evidence. Among correlated (r2 > 0.5) SNPs 
with UC GWAS P values < 1×10−4, only the SNP with the most significant P value was 
chosen as the “best region” SNP and placed on the replication candidate list. Other 
replication genotyping candidates included a) SNPs at previously implicated CD or UC loci 
or their best UC GWAS proxies (r2 > 0.5 in a 1 Mb window of HapMap CEU data23 
centered on the implicated SNP) that showed nominal evidence for association (P < 0.05) in 
our UC GWAS, and b) previously implicated SNPs that did not have a proxy in our UC 
GWAS. Finally, additional SNPs from loci that demonstrated genome-wide significant 
evidence for association were added to the replication candidate list. rs6426833, rs2395185 
and rs1558744 were genotyped by Pyrosequencing (Biotage AB, Uppsala, Sweden) at the 
University of Pittsburgh. SNPs on the replication candidate list that had designable 
Sequenom iPlex (Sequenom, San Diego, CA) assays and could be multiplexed in three 
oligonucleotide pools were genotyped on the Sequenom MassArray platform at the 
University of Pittsburgh (North American samples and some of the Italian sample 
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genotyping) and the Montreal Heart Institute (Italian samples). Samples with high 
genotyping failure rates were attempted a second time. Data management and quality control 
filtering are described in the Supplementary Methods online. Association evidence in the 
two replication samples was assessed using the Cochran-Mantel-Haenszel (CMH) test, and 
the Fisher method was used to combine UC GWAS GEM P values and replication CMH P 
values. SNPs with combined P values < 5×10−8 were considered to have genome-wide 
significant evidence for association27. SNPs with genome-wide significant evidence for 
association in the UC GWAS and CMH P values < 0.05 in the replication samples were 
considered to have confirmed association with UC.
Parents of UC GWAS and replication sample cases with available DNA samples were also 
genotyped, and affected offspring trios were analyzed using the transmission/disequilibrium 
test15 (see Supplementary Table 1 online).
Conditional analysis
We were interested in whether one or more causal SNPs might explain the observed 
association in regions showing genome-wide significant association with UC. To explore 
this question we fit a conditional logistic model, with pairs of SNPs in the model, 
conditional on ancestry and gender. P values for the SNPs are interpretable as the residual 
variation explained by the SNP, conditional on the inclusion of the other SNP. Significant 
residual association signal was defined as P < 0.05 in the conditional analysis. We also 
computed pairwise r2 values in our GWAS control data for the same pairs of SNPs.
Demarcation of regions containing genome-wide significant association signals
We demarcated regions containing genome-wide significant association signals by first 
defining the set of SNPs with r2 > 0.5 to all independent SNPs showing genome-wide 
significant association using a 1 Mb window of HapMap CEU data23 centered on the index 
SNP. SNPs were considered to be independent if they had a r2 < 0.3 in our GWAS control 
data. Recombination hotspots28 flanking these sets of SNPs were set as the boundaries of 
regions containing genome-wide significant association signals.
Power analysis
A post hoc power analysis was computed for a two-stage study design with parameters 
similar to our study design using the CaTS software26 (see Supplementary Table 5 online).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Association signals and recombination rates for loci demonstrating genome-wide significant 
association with UC on chromosomes a) 1p36, b) 1p31, c) 6p21 and d) 12q15. The vertical 
axis scale on the left side of each plot represents the –log10 of the P values. The vertical axis 
scale on the right side of each plot represents the recombination rate in cM/Mb. The UC 
GWAS –log10 GEM P values are plotted as small diamonds (all arrays shared SNPs GEM 
dataset, see Supplementary Table 1 online) and small circles (HumanHap550 only SNPs 
GEM dataset, see Supplementary Table 1 online). Linkage disequilibrium (r2) in the GWAS 
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control data to the single most significantly associated regional SNP is color-coded (red: r2 
greater than 0.8; orange: r2 0.5−0.8; yellow: r2 0.2−0.5; white: r2 less than 0.2). Large blue 
diamonds with corresponding rs number and P value labels represent combined UC GWAS 
and replication case-control significance estimates. Light blue lines represent the 
recombination rates. Conditional analyses (see Supplementary Table 3 online) of replicated 
markers (large blue diamonds) suggest the presence of independent association signals on 
chromosome 1p36 and on chromosome 12q15 separated by recombination hotspots.
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